James T. Borello RIA
REGN icon

James T. Borello RIA’s Regeneron Pharmaceuticals REGN Stock Holding History

James T. Borello RIA’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$33.4K Sell
44
-1
-2% -$756 0.01% 310
2026
Q2 		$28.1K Buy
45
+7
+18% +$4.76K 0.01% 331
2026
Q1 		$29.4K Buy
38
+12
+46% +$9.19K 0.01% 296
2025
Q4 		$20.1K Buy
26
+14
+117% +$9.5K 0.01% 279
2025
Q3 		$6.75K Buy
+12
New +$6.78K ﹤0.01% 376

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
Atwood & Palmer
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Loring Wolcott & Coolidge Fiduciary Advisors
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.8B AUM 9.05% 1-Year Est. Return
LMCG Investments
LMCG Investments Boston, Massachusetts $1.86B AUM 40.01% 1-Year Est. Return

James T. Borello RIA's REGN Position: Q3 2026 in Review

James T. Borello RIA reduced its Regeneron Pharmaceuticals (REGN) stake by 2.2% in Q3 2026, selling an estimated $756 and leaving 44 shares worth $33.4K. The position accounts for 0.01% of the portfolio, ranked #310.

James T. Borello RIA first reported a position in REGN in Q3 2025 and has held it in 5 quarters since. 368 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • James T. Borello RIA held 44 shares of Regeneron Pharmaceuticals worth $33.4K as of Q3 2026.
  • James T. Borello RIA sold 1 Regeneron Pharmaceuticals share in Q3 2026, an estimated $756.
  • Regeneron Pharmaceuticals made up 0.01% of James T. Borello RIA's portfolio in Q3 2026, its #310 holding.
  • James T. Borello RIA first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • 368 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on James T. Borello RIA's 13F filing for Q3 2026, filed 16 Oct 2026.